1. Home
  2. FNA vs BRSP Comparison

FNA vs BRSP Comparison

Compare FNA & BRSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FNA
  • BRSP
  • Stock Information
  • Founded
  • FNA 2010
  • BRSP 2017
  • Country
  • FNA United States
  • BRSP United States
  • Employees
  • FNA N/A
  • BRSP N/A
  • Industry
  • FNA Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • BRSP Real Estate Investment Trusts
  • Sector
  • FNA Health Care
  • BRSP Real Estate
  • Exchange
  • FNA Nasdaq
  • BRSP Nasdaq
  • Market Cap
  • FNA 852.1M
  • BRSP 806.6M
  • IPO Year
  • FNA 2021
  • BRSP 2018
  • Fundamental
  • Price
  • FNA $10.70
  • BRSP $6.11
  • Analyst Decision
  • FNA Strong Buy
  • BRSP Hold
  • Analyst Count
  • FNA 5
  • BRSP 5
  • Target Price
  • FNA $15.60
  • BRSP $7.06
  • AVG Volume (30 Days)
  • FNA 550.3K
  • BRSP 381.3K
  • Earning Date
  • FNA 11-12-2024
  • BRSP 10-29-2024
  • Dividend Yield
  • FNA N/A
  • BRSP 10.30%
  • EPS Growth
  • FNA N/A
  • BRSP N/A
  • EPS
  • FNA N/A
  • BRSP N/A
  • Revenue
  • FNA $244,995,000.00
  • BRSP $378,095,000.00
  • Revenue This Year
  • FNA $18.58
  • BRSP N/A
  • Revenue Next Year
  • FNA $14.85
  • BRSP N/A
  • P/E Ratio
  • FNA N/A
  • BRSP N/A
  • Revenue Growth
  • FNA 18.16
  • BRSP N/A
  • 52 Week Low
  • FNA $4.65
  • BRSP $5.07
  • 52 Week High
  • FNA $14.79
  • BRSP $8.01
  • Technical
  • Relative Strength Index (RSI)
  • FNA 60.03
  • BRSP 49.36
  • Support Level
  • FNA $10.19
  • BRSP $6.15
  • Resistance Level
  • FNA $11.00
  • BRSP $6.37
  • Average True Range (ATR)
  • FNA 0.51
  • BRSP 0.12
  • MACD
  • FNA -0.13
  • BRSP -0.04
  • Stochastic Oscillator
  • FNA 43.20
  • BRSP 21.24

About FNA Paragon 28 Inc.

Paragon 28 Inc is a medical devices company that develops, distributes, and sells medical devices in the foot and ankle segment of the orthopedic implant marketplace. Its products include plates and plating systems, screws, staples, and nails aimed to address all major foot and ankle procedures including ankle, Charcot, fracture fixation, hallux valgus, hammertoe, and flat foot. The company's suite of surgical solutions comprises nearly 80 product systems to help fit the specific needs of each patient and procedure. Geographically the company generates the majority of its revenue from the United States.

About BRSP BrightSpire Capital Inc.

BrightSpire Capital Inc is an internally-managed commercial real estate credit REIT focused on originating, acquiring, financing and managing a diversified portfolio of commercial real estate debt and net lease real estate investments predominantly in the United States. CRE debt investments consist of first mortgage loans with the objective of generating consistent risk-adjusted returns. The operating segments of the company are Senior and Mezzanine Loans and Preferred Equity, Net Leased and Other Real Estate, Corporate and Other. Geographically, the company generates revenue from the United States.

Share on Social Networks: